Stockholders' equity - Schedule of equity awards (Detail) - Employee stock option - $ / shares |
3 Months Ended | |
|---|---|---|
Jun. 30, 2022 |
Sep. 30, 2022 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Stock Options,Outstanding, beginning of period | 738,064 | |
| Stock Options, Expired | 5,665 | |
| Stock Options, Outstanding, end of period | 738,064 | 732,399 |
| Stock Options, Exercisable, end of period | 269,509 | |
| Weighted-average Exercise price, beginning of period | $ 6.95 | |
| Weighted-average Exercise Price, Expired | 45.92 | |
| Weighted-average Exercise Price, Exercise price, end of period | $ 6.95 | 6.65 |
| Weighted-average Exercise Price, Exercisable, end of period | $ 12.47 | |
| Weighted-average Remaining Contractual Term, Outstanding | 7 years 2 months 4 days | 6 years 11 months 26 days |
| Weighted-average Remaining Contractual Term, Exercisable | 6 years 21 days |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|